Instruments, modules, and methods for improved detection of edited sequences in live cells

Patent metadata

Field	Value
Publication number	US-11739290-B2
Application number	US-202117555336-A
Country	US
Kind code	B2
Filing date	Dec 17, 2021
Priority date	Aug 14, 2018
Publication date	Aug 29, 2023
Grant date	Aug 29, 2023

Abstract

The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.

First claim

We claim:

1. A method for enriching edited cells comprising:
transforming cells with one or more vectors comprising a first promoter driving transcription of a coding sequence for a CRISPR nuclease and a second promoter driving transcription of a guide nucleic acid sequence;
diluting the transformed cells to a cell concentration to substantially cingulate the transformed cells; growing the substantially singulated transformed cells;
initiating editing by inducing the second promoter for driving transcription of the guide nucleic acid sequence;
growing the edited cells to form colonies; and
selecting or pooling slow-growing colonies, of the colonies, wherein cells from the slow-growing colonies are enriched for edited cells.

2. The method of claim 1 , wherein at least one of the first promoter or the second promoter is an inducible promoter.

3. The method of claim 1 , wherein the coding sequence for the CRISPR nuclease and the guide nucleic acid sequence are on a same vector.

4. The method of claim 1 , wherein the coding sequence for the CRISPR nuclease is on a first vector and the guide nucleic acid sequence is on a second vector.

5. The method of claim 1 , wherein the cells are further transformed with a DNA donor sequence comprising a PAM-altering sequence.

6. The method of claim 1 , wherein the edited cells are one or more of mammalian cells, yeast cells, or bacterial cells.

7. The method of claim 1 , wherein the substantially singulated transformed cells are grown on at least one of a substrate or a solid wall device for at least 5 doublings.

8. The method of claim 1 , wherein each of the one or more vectors comprises a gene for a selectable marker.

9. The method of claim 1 , wherein the one or more vectors further comprises a recombineering system.

10. The method of claim 1 , wherein the transformed cells are substantially singulated on a substrate, the substrate selected from at least one of an agar plate and a device with solid walls.

11. The method of claim 10 , wherein the device with solid walls is a solid wall isolation, induction, and normalization (SWIIN) device.

12. A method for enriching edited comprising:
transforming cells with one or more vectors comprising a first promoter driving transcription of a coding sequence for a CRISPR nuclease and a second promoter driving transcription of a guide nucleic acid sequence;
diluting the transformed cells to a cell concentration to substantially cingulate the transformed cells;
growing the substantially singulated transformed cells until the substantially singulated transformed cells establish colonies having respective colony sizes;
initiating editing by inducing the second promoter;
growing the edited cells to form colonies of terminal size; and
harvesting the colonies of terminal size.

13. The method of claim 12 , wherein at least one of the first promoter or the second promoter is an inducible.

14. The method of claim 12 , wherein the transformed cells are substantially singulated on a solid wall device, the solid wall device being a solid wall isolation, induction, and normalization (SWIIN) device.

15. The method of claim 12 , wherein the one or more vectors each comprise a selectable marker and further comprising adding selective agents to select for the one or more vectors.

16. The method of claim 12 , wherein the CRISPR nuclease is a CRISPR enzyme.

17. The method of claim 12 , further comprising pooling the terminal size colonies.

18. The method of claim 17 , further comprising:
transforming second cells of the pooled terminal size colonies with the one or more vectors;
diluting the transformed second cells to a second cell concentration to substantially singulate the transformed second cells;
growing the substantially singulated transformed second cells until the substantially singulated transformed second cells establish colonies having respective colony sizes;
initiating editing of the second cells by inducing the second promoter; and
growing the edited second cells to form second colonies of terminal size.

19. The method of claim 12 , wherein the transformed cells are at least one of mammalian cells or bacterial cells and the one or more vectors further comprise a recombineering system.

20. The method of claim 12 , wherein the substantially singulated transformed cells are grown on at least one of a substrate or a solid wall device for at least 5 doublings.

Assignees

• Inscripta Inc

Inventors

• Garst Andrew
• Fox Richard
• Belgrader Phillip
• Masquelier Don

Classifications

• B01D71/0213

  Silicon · CPC title

• B01D63/082

  comprising a stack of flat membranes · CPC title

• B01D2313/50

  Specific extra tanks · CPC title

• B01D69/06

  Flat membranes · CPC title

• C12M45/07

  by electrical or electromagnetic forces · CPC title